Basic Information
ID: ALA4681404
Type: ADME
Description: Drug metabolism in human liver S9 fractions assessed as AO-mediated mono-oxidised metabolite formation at 10 uM incubated for 60 mins in absence of CYP cofactor NADP and in presence of 50 uM XO inhibitor allopurinol by HPLC-UV chromatography
Format: BAO_0000220
Organism: Homo sapiens
Tissue: Liver
Subcellular Fraction: S9
Target: Aldehyde oxidase(ALA3257)
Document: ALA4680090
Drug metabolism in human liver S9 fractions assessed as AO-mediated mono-oxidised metabolite formation at 10 uM incubated for 60 mins in absence of CYP cofactor NADP and in presence of 50 uM XO inhibitor allopurinol by HPLC-UV chromatography: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4681404
Drug metabolism
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 440.46 | 2.66 | 2.66 |